Replimune Group, Inc. REPL
12.36
(0.24)
(1.90%)
as of 25 Sep
- Market cap
- $1.2B
- P/E
- 0.0×
Follow REPL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
6.31 | 5.60 | 4.79 | 5.23 |
Net Debt/EBITDA |
2.99 | 2.80 | 2.25 | 1.34 | |
Debt/Assets |
17.86% | 20.91% | 31.65% | 41.91% | |
Debt/Equity |
0.26 | 0.33 | 0.63 | 1.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.98 | 0.93 | 0.77 | 1.09 | |
Capex/Depreciation |
1.89 | (0.19) | (0.01) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.90) | (0.72) | (0.61) | (0.78) | |
Cash per Share |
3.52 | 2.92 | 2.90 | 2.02 | |
Shareholders Equity per Share |
2.87 | 2.28 | 1.79 | 1.09 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.87 | 2.28 | 1.79 | 1.09 | |
Free Cash Flow |
(82.55) | (66.09) | (56.17) | (75.73) | |
Working Capital |
280.85 | 230.27 | 220.89 | 162.40 | |
Capital Expenditures |
(1.34) | (0.13) | 0.00 | (0.01) | |
Net Current Asset Value |
207.64 | 157.30 | 112.89 | 54.01 | |
| Other line items | |||||
Quick Ratio |
6.15 | 5.43 | 4.65 | 5.09 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.88) | (0.72) | (0.61) | (0.78) | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Average Receivables |
1.93 | 3.01 | 2.67 | — | |
Average Payables |
7.41 | 6.42 | 9.57 | 9.87 | |
Average Assets |
443.83 | 468.61 | 441.86 | 360.98 | |
Average Common Equity |
322.40 | 346.46 | 291.00 | 221.18 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates